Granular Psyllium Laxative Reclassification Unsupported – Madaus
This article was originally published in The Tan Sheet
Executive Summary
FDA's proposed prohibition on the use of bulk-forming laxative psyllium ingredients in granular dosage form is based on "biased, incomplete, confused, and highly selective" information, according to ingredient manufacturer Madaus AG
You may also be interested in...
Granular Psyllium Laxatives Category II Classification Advised – FDA
FDA is proposing to declare that bulk-forming psyllium ingredients in granular form are not safe for use in OTC laxatives
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands